Minayoshi, Y.; Maeda, H.; Hamasaki, K.; Nagasaki, T.; Takano, M.; Fukuda, R.; Mizuta, Y.; Tanaka, M.; Sasaki, Y.; Otagiri, M.;
et al. Mouse Type-I Interferon-Mannosylated Albumin Fusion Protein for the Treatment of Chronic Hepatitis. Pharmaceuticals 2024, 17, 260.
https://doi.org/10.3390/ph17020260
AMA Style
Minayoshi Y, Maeda H, Hamasaki K, Nagasaki T, Takano M, Fukuda R, Mizuta Y, Tanaka M, Sasaki Y, Otagiri M,
et al. Mouse Type-I Interferon-Mannosylated Albumin Fusion Protein for the Treatment of Chronic Hepatitis. Pharmaceuticals. 2024; 17(2):260.
https://doi.org/10.3390/ph17020260
Chicago/Turabian Style
Minayoshi, Yuki, Hitoshi Maeda, Keisuke Hamasaki, Taisei Nagasaki, Mei Takano, Ryo Fukuda, Yuki Mizuta, Motohiko Tanaka, Yutaka Sasaki, Masaki Otagiri,
and et al. 2024. "Mouse Type-I Interferon-Mannosylated Albumin Fusion Protein for the Treatment of Chronic Hepatitis" Pharmaceuticals 17, no. 2: 260.
https://doi.org/10.3390/ph17020260
APA Style
Minayoshi, Y., Maeda, H., Hamasaki, K., Nagasaki, T., Takano, M., Fukuda, R., Mizuta, Y., Tanaka, M., Sasaki, Y., Otagiri, M., Watanabe, H., & Maruyama, T.
(2024). Mouse Type-I Interferon-Mannosylated Albumin Fusion Protein for the Treatment of Chronic Hepatitis. Pharmaceuticals, 17(2), 260.
https://doi.org/10.3390/ph17020260
